Medicine Man Technologies (Medicine Man Technologies) Risk Assessment

View and export this data going back to 2015. Start your Free Trial

What is Medicine Man Technologies Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Medicine Man Technologies is: High Risk: High uncertainty.

Competitive Comparison of Medicine Man Technologies's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Medicine Man Technologies's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicine Man Technologies's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicine Man Technologies's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Medicine Man Technologies's Risk Assessment falls into.

Medicine Man Technologies (OTCPK:SHWZ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Medicine Man Technologies Risk Assessment Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicine Man Technologies (Medicine Man Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicine Man Technologies Inc (OTCPK:SHWZ) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

SHWZ:Canada

Address

4880 Havana Street, Suite 201, Denver, CO, USA, 80239

Website

https://www.schwazze.com

Medicine Man Technologies Inc is engaged in providing general consulting services in the cannabis industry. The company also provide seminar which includes giving guidance and tips on industry opportunities, medical and recreational market trends, cultivation methodologies and technology, extraction technology, dispensary operation, security requirements. The company's operating segment includes- Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products; Other, consisting of all other income and expenses. It generates maximum revenue from the Retail segment. The company is now operating under its new trade name, Schwazze.

Executives

Christine Jones	officer: Chief Legal Officer	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Forrest Hoffmaster	officer: CFO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Nirup Krishnamurthy	director, officer: President	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Kathy P Vrabeck	director	625 WESTPORT PARKWAY, GRAPEVINE TX 76051
Jeff Garwood	director	55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915
Pratap Chandra Mukharji	director	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Salim Husan Wahdan	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Paul Joseph Montalbano	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Brad Stewart	director	C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017
Justin Dye	director, 10 percent owner, officer: CEO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Jeffrey Alley Cozad	director, 10 percent owner	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Crw Capital Holdings Ii, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209
Crw Capital, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Crw Capital Cann Holdings, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Brian Ruden	10 percent owner	C/O 4880 HAVANA STREET, SUITE 102, DENVER CO 80239